A Study of Immune Responses and ECMO in Severe Lung Injury
Part of Lungs & breathing clinical trials.
This study looks at how the immune system and ECMO (a machine that helps oxygenate blood) can improve outcomes for people with moderate to severe ARDS. If you join, researchers will monitor your condition and treatment to find better ways to manage this serious lung problem.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years of age or older.
- You must have moderate to severe ARDS, which is a severe lung injury causing low oxygen levels.
- You must not have a tracheostomy (a breathing tube in your neck) already in place.
- You must not have had a lung transplant or be using ECMO as a bridge to a transplant.
- You must not have cardiogenic shock that requires special ECMO setups (VA or VAV).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of very gentle breathing settings on a ventilator paired with a temporary heart-lung machine (ECMO) to help patients with severe acute respiratory distress syndrome (ARDS) recover. The goal is to protect your lungs from further injury while they heal.
This trial looks at how the immune system might cause severe breathing problems (ARDS). It may help doctors understand what happens in the lungs during this condition and find better ways to treat it.
This trial observes the symptoms, treatments, and recovery of patients with acute respiratory distress syndrome (ARDS), a serious lung condition. It aims to learn more about how different types of breathing support affect outcomes.
This trial studies two ways to measure how much of your lungs can open up again (recruitability) to help doctors set the best breathing machine pressure. It may help improve oxygen levels in patients with severe lung injury.
This trial tests a full-course strategy using a heart-lung bypass machine (ECMO) for people with moderate-to-severe acute respiratory distress syndrome (ARDS), a serious lung condition. The goal is to see if starting and continuing ECMO throughout treatment improves recovery.
This trial looks at how changes in lung pressure during breathing might affect recovery in patients with severe ARDS who are on a heart-lung bypass machine (ECMO). It could help doctors improve treatment for people with this serious lung condition.
Hear when a new Acute Respiratory Distress Syndrome (ARDS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.